Replay available

Organigram Global Inc. (OGI) Q2 2025 Earnings Call

Organigram Global Inc. (NASDAQ: OGI) Q2 2025 earnings conference call, held 2025-05-12. Replay captured from the company's public earnings webcast.

Mon, May 12, 2025 at 8:00 AMendedReplay
Organigram Global Inc. (OGI) Q2 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Yiwan Kang

Analyst, Canaccord Genuity

Bina Goldenberg

Chief Executive Officer, Organigram Global Inc.

Max Schwartz

Investor Relations, Organigram Global Inc.

Federico Gomes

Analyst, ATB Capital Markets

Erin Gray

Analyst, Alliance Global Partners

Greg Guyot

Chief Financial Officer, Organigram Global Inc.

Replay transcript excerpt

Good morning. My name is Krista, and I will be your conference operator today. At this time, I would like to welcome everyone to the Organigram Global Second Quarter Fiscal 2025 Earnings Conference Call. After the speaker's remarks, there will be a question and answer session. We ask that you please limit yourself to one question and one follow-up. You may recue if you have any questions. Thank you. Max Schwartz, you may begin your conference. Thank you very much and good morning, everyone. Thanks for joining us today. As a reminder, this conference call is being recorded and recording will be available on OrganiGram's website 24 hours after today's call. Listeners should be aware that today's call will include estimates and other forward-looking information from which the company's actual results could differ. Please review the cautionary language in our press release dated May 12, 2025 on various factors, assumptions, and risks that could cause our actual results to differ. Further reference will be made to certain non-IFRS measures during this call, including adjusted EBITDA, adjusted gross margin, and adjusted gross margin percentage. These measures do not have any standardized meaning under IFRS and are intended to provide additional information and as such should not be considered in isolation or as a substitute for measures of performance repaired in accordance with IFRS. Our approach to calculating these measures may differ from other issuers, so these measures may not be directly comparable. Please see today's earnings report for more information about these measures. Listeners should be aware that the company relies on reputable third-party providers in making certain statements relating to market share data. Unless otherwise indicated, all references to ma...

More from Organigram Global Inc.